196 related articles for article (PubMed ID: 15992579)
1. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells.
Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P
Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.
Mahé C; Bernhard M; Bobirnac I; Keser C; Loetscher E; Feuerbach D; Dev KK; Schoeffter P
Br J Pharmacol; 2004 Oct; 143(3):404-10. PubMed ID: 15339860
[TBL] [Abstract][Full Text] [Related]
3. Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes.
Hirst WD; Price GW; Rattray M; Wilkin GP
Br J Pharmacol; 1997 Feb; 120(3):509-15. PubMed ID: 9031757
[TBL] [Abstract][Full Text] [Related]
4. Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus.
Duncan MJ; Grear KE; Hoskins MA
Brain Res; 2004 May; 1008(1):40-8. PubMed ID: 15081380
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
6. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
[TBL] [Abstract][Full Text] [Related]
7. Serotonin (5-HT7) receptor-stimulated activation of cAMP-PKA pathway in bovine corneal epithelial and endothelial cells.
Grueb M; Rohrbach JM; Schlote T; Mielke J
Ophthalmic Res; 2012; 48(1):22-7. PubMed ID: 22222787
[TBL] [Abstract][Full Text] [Related]
8. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
10. The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies.
Roberts C; Allen L; Langmead CJ; Hagan JJ; Middlemiss DN; Price GW
Br J Pharmacol; 2001 Apr; 132(7):1574-80. PubMed ID: 11264252
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
12. Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells.
Schoeffter P; Ullmer C; Gutierrez M; Weitz-Schmidt G; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):580-2. PubMed ID: 8751089
[TBL] [Abstract][Full Text] [Related]
13. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization.
Chapin EM; Andrade R
J Pharmacol Exp Ther; 2001 Apr; 297(1):395-402. PubMed ID: 11259568
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
15. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of 5-HT⁷ receptor on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice.
Yang EJ; Han SK; Park SJ
Brain Res; 2014 Jan; 1543():73-82. PubMed ID: 24516875
[TBL] [Abstract][Full Text] [Related]
17. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
18. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
Sprouse J; Reynolds L; Li X; Braselton J; Schmidt A
Neuropharmacology; 2004 Jan; 46(1):52-62. PubMed ID: 14654097
[TBL] [Abstract][Full Text] [Related]
19. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
Hemedah M; Coupar IM; Mitchelson FJ
Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
[TBL] [Abstract][Full Text] [Related]
20. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
